Healthtech funding in 2026
European Healthtech startup funding raised during 2026.
In 2026, 372 European Healthtech companies closed 390 funding rounds and raised €12B in equity funding (excluding debt and grants). Debt rounds added €510M. UK led by capital raised, and High-Tech Gründerfonds (HTGF) was the most active investor. Data as of 20 Nov 2026.
Equity funding
€12B
excl. debt & grants · +€510M debt
Funding rounds
390
Companies
372
Top country
UK
Healthtech: last three years
2026 is to date; no change shown against a full yearBreak down 2026 by period
in progress — period is still running
Rank among sectors
#3
12.8% of sector funding
Debt financing
€510M
4.2% of total
Top-10 round share
67.1%
of disclosed capital
Rounds ≥ €100M
11
Funding by month
€ raised vs rounds, by monthHealthtech — funding by month, 2026 — interactive chart.
Data table
| Funding | Rounds | |
|---|---|---|
| Jan | €850M | 51 |
| Feb | €446M | 40 |
| Mar | €279M | 42 |
| Apr | €253M | 35 |
| May | €2.0B | 33 |
| Jun | €486M | 36 |
| Jul | €812M | 31 |
| Aug | €245M | 20 |
| Sep | €833M | 38 |
| Oct | €1.3B | 32 |
| Nov | €4.8B | 32 |
Top countries
by € raisedHealthtech — top countries by capital, 2026 — interactive chart.
Data table
| Healthtech — top countries by capital, 2026 | |
|---|---|
| UK | €8.4B |
| Sweden | €899M |
| France | €660M |
| Switzerland | €532M |
| Germany | €410M |
| Spain | €349M |
| Netherlands | €250M |
| Denmark | €157M |
Stage mix
by € raisedHealthtech — stage mix, 2026 — interactive chart.
Data table
| Healthtech — stage mix, 2026 | |
|---|---|
| Series C | €5.9B |
| Series B | €2.5B |
| Other | €1.4B |
| Series A | €737M |
| Debt | €510M |
| Growth/Late | €448M |
| Seed | €365M |
| Series D+ | €320M |
| Grant | €70M |
| Pre-Seed | €48M |
| Crowdfunding | €233k |
Exits & M&A
24 Acquisition24 exits · €1.0B disclosed.
| Saga Diagnostics | Acquisition | Apr 2026 | €504M |
| Kaia Health | Acquisition | Jan 2026 | €239M |
| Gleamer | Acquisition | Mar 2026 | €230M |
Largest equity rounds
by disclosed amount, 2026| Company | Stage | Date | Amount |
|---|---|---|---|
| Isomorphic Labs | Series C | Nov 2026 | €4.6B |
| Isomorphic Labs | Series B | May 2026 | €1.8B |
| Neko Health | Series C | Jul 2026 | €614M |
| CMR Surgical | Growth/Late | Oct 2026 | €355M |
| OMass Therapeutics | Series C | Oct 2026 | €273M |
| Oviva | Series D+ | Jan 2026 | €200M |
| Basecamp Research | Series C | Sep 2026 | €123M |
| Nouscom | Series B | Oct 2026 | €120M |
| CeQur | Series D+ | Jun 2026 | €86M |
| HighLife | Other | Sep 2026 | €80M |
Largest debt rounds
debt financing, 2026; not in the equity totalTop investors
most active in 2026, by deal count- High-Tech Gründerfonds (HTGF)13 deals
- European Investment Bank (EIB)10 deals
- Venture Kick10 deals
- Innovate UK8 deals
- BioInnovation Institute6 deals
- EIC Fund6 deals
- IBB Ventures6 deals
- Sofinnova Partners6 deals
- Y Combinator6 deals
- Angelini Ventures5 deals
Source: Tech.eu Funding Explorer · data as of 20 Nov 2026 · licence CC BY 4.0 · Methodology